drugset / Trial / NCT02792946

Compare the Efficacy and Safety of Surfolase CR Tablet With Surfolase Capsule in Patients With Acute Bronchitis

NCT02792946 ↗

Phase 3 Completed 244 enrolled Hyundai Pharmaceutical Co., LTD.
RandomizedParallel-groupTriple-blindTreatment

Summary

Compare the efficacy and safety of surfolase CR tablet with surfolate capsule in patients with acute bronchitis

Timeline

Start
2015-11
Primary completion
2016-01
Completion
2016-01

Drugs

EvaluationDrugModalityDoseRoute
Subject AMBROXOL ACEFYLLINATE Small molecule 100 mg —
Subject AMBROXOL ACEFYLLINATE Small molecule 200 mg —

Indications